TracyRenee(Mcmillan)LuckhardtMD(She/Her)

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, University of Alabama at Birmingham School of Medicine

Dr. Luckhardt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a board certified Pulmonary and Critical Care physician. I specialize in the diagnosis and treatment of Interstitial Lung Disease, including Idiopathic Pulmonary Fibrosis (IPF), ILD related to autoimmune disease and all other diffuse parenchymal disease. I am principal investigator on multiple industry-sponsored clinical trials in Interstitial Lung Disease.

University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2000 - 2004
LSU School of Medicine in ShreveportClass of 2000

PubMed

33 citations
Systemic Sclerosis-Associated Fibrosis: An Accelerated Aging Phenotype?
Tracy Luckhardt, Victor J. Thannickal
Current Opinion in Rheumatology. 2015-11-01
652 citations
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Louise Hecker, Ragini Vittal, Tamara R. Jones, Rajesh Jagirdar, Tracy Luckhardt
Nature Medicine. 2009-09-01
139 citations
Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease.
Chunsun Jiang, Gang Liu, Tracy Luckhardt, Veena B. Antony, Yong Zhou
Aging Cell. 2017-07-19

The Summer Coronavirus Surge Has Started to Ebb, but Delta’s Danger RemainsAugust 19th, 2021
Precision Medicine: UAB Study Creates ‘Mini-Lung’ to Study Effect of Pulmonary Fibrosis DrugsJanuary 26th, 2017